{"id":"W2415117000","doi":"10.1016/j.jlr.2026.101063","title":"PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role","year":2016,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"Regeneron Pharmaceuticals; GlaxoSmithKline; AstraZeneca; Daiichi-Sankyo; Fondation Leducq; Pfizer; Amgen; Bristol-Myers Squibb; Eisai; Sanofi; Abbott Laboratories","keywords":"Evolocumab; PCSK9; Kexin; LDL receptor; Internal medicine; Endocrinology; Lipoprotein(a); Quartile; Lipoprotein; Monoclonal antibody; Medicine; Internalization; Low-density lipoprotein; Alirocumab; Receptor; Cholesterol; Chemistry; Antibody; Immunology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06642368,0.00008745579,0.001244414,0.0009005341,0.00006942789,0.00002135341,0.0001020244,0.0001445851,0.0002750605],"category_scores_gemma":[0.007341061,0.00003592017,0.0004316503,0.001240693,0.0005352465,0.0001769583,0.00003492858,0.0006407714,0.000004645086],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001217398,"about_ca_system_score_gemma":0.0006137756,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002199601,"about_ca_topic_score_gemma":0.00006816239,"domain_scores_codex":[0.9913938,0.005313676,0.001345959,0.0001923789,0.001507981,0.0002461782],"domain_scores_gemma":[0.9959012,0.001637698,0.0005226822,0.0004180868,0.001248348,0.0002720338],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1107569,0.00290158,0.1863049,0.0003591651,0.0153054,0.0001765275,0.003129374,0.0001077123,0.06486525,0.0006387488,0.005835724,0.6096187],"study_design_scores_gemma":[0.1136638,0.0228834,0.7888185,0.003578647,0.00535853,0.001004042,0.01227126,0.001513494,0.01655495,0.0009500161,0.03288243,0.0005209511],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906139,0.0009633383,0.00006905859,0.007518221,0.0001001518,0.0004613746,0.000006047187,0.00000363082,0.000264286],"genre_scores_gemma":[0.9948376,0.003156682,0.0002156668,0.00002587015,0.001536329,0.00001051364,0.000003969198,0.00001214213,0.000201221],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6090977,"threshold_uncertainty_score":0.9613133,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1269059781196437,"score_gpt":0.4673184434497075,"score_spread":0.3404124653300638,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}